United Therapeutics (UTHR) Interest Coverage Ratio (2009 - 2026)

United Therapeutics has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 114.07 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio rose 128.45% year-over-year to 114.07; the TTM figure through Jun 2026 stood at 116.82 (up 153.3% YoY), while the FY2025 annual figure was 76.54, up 138.45% from the prior year.
• Interest Coverage Ratio came in at 114.07 for Q2 2026 at United Therapeutics, up from 108.6 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 129.5 in Q3 2025 to a low of 14.28 in Q4 2022.
• Average Interest Coverage Ratio over 5 years is 51.99, with a median of 34.07 recorded in 2022.
• Year-over-year, Interest Coverage Ratio jumped 534.99% in 2022 and plunged 66.37% in 2023.
• Over 5 years, Interest Coverage Ratio stood at 14.28 in 2022, then grew by 20.65% to 17.23 in 2023, then soared by 162.86% to 45.28 in 2024, then surged by 154.13% to 115.06 in 2025, then fell by 0.87% to 114.07 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 114.07 in Q2 2026, 108.6 in Q1 2026, and 115.06 in Q4 2025.